<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39349769</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Using random forest and biomarkers for differentiating COVID-19 and Mycoplasma pneumoniae infections.</ArticleTitle><Pagination><StartPage>22673</StartPage><MedlinePgn>22673</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22673</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-74057-5</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has underscored the critical need for precise diagnostic methods to distinguish between similar respiratory infections, such as COVID-19 and Mycoplasma pneumoniae (MP). Identifying key biomarkers and utilizing machine learning techniques, such as random forest analysis, can significantly improve diagnostic accuracy. We conducted a retrospective analysis of clinical and laboratory data from 214 patients with acute respiratory infections, collected between October 2022 and October 2023 at the Second Hospital of Nanping. The study population was categorized into three groups: COVID-19 positive (n = 52), MP positive (n = 140), and co-infected (n = 22). Key biomarkers, including C-reactive protein (CRP), procalcitonin (PCT), interleukin- 6 (IL-6), and white blood cell (WBC) counts, were evaluated. Correlation analyses were conducted to assess relationships between biomarkers within each group. The random forest analysis was applied to evaluate the discriminative power of these biomarkers. The random forest model demonstrated high classification performance, with area under the ROC curve (AUC) scores of 0.86 (95% CI: 0.70-0.97) for COVID-19, 0.79 (95% CI: 0.64-0.92) for MP, 0.69 (95% CI: 0.50-0.87) for co-infections, and 0.90 (95% CI: 0.83-0.95) for the micro-average ROC. Additionally, the precision-recall curve for the random forest classifier showed a micro-average AUC of 0.80 (95% CI: 0.69-0.91). Confusion matrices highlighted the model's accuracy (0.77) and biomarker relationships. The SHAP feature importance analysis indicated that age (0.27), CRP (0.25), IL6 (0.14), and PCT (0.14) were the most significant predictors. The integration of computational methods, particularly random forest analysis, in evaluating clinical and biomarker data presents a promising approach for enhancing diagnostic processes for infectious diseases. Our findings support the use of specific biomarkers in differentiating between COVID-19 and MP, potentially leading to more targeted and effective diagnostic strategies. This study underscores the potential of machine learning techniques in improving disease classification in the era of precision medicine.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Xun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Second Hospital of Nanping, Nanping, 354200, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fuding Hospital, Fujian University of Traditional Chinese Medicine, 120 South Road of Old City, Fuding, 355200, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Deng</LastName><ForeName>Xiu-Mei</ForeName><Initials>XM</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Second Hospital of Nanping, Nanping, 354200, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Fang-Mei</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Second Hospital of Nanping, Nanping, 354200, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Juan-Min</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Second Hospital of Nanping, Nanping, 354200, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhong-Yuan</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, 353000, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xian-Qiang</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Jianyang District Centre for Disease Control and Prevention, Nanping, 354200, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yue-Xing</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Second Hospital of Nanping, Nanping, 354200, Fujian, China. 419355539@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shi-Yan</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0003-4305-8213</Identifier><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Fuding Hospital, Fujian University of Traditional Chinese Medicine, 120 South Road of Old City, Fuding, 355200, Fujian, China. myebox@139.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022J54</GrantID><Agency>Natural Science Foundation Joint Project of Ningde, China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011019" MajorTopicYN="Y">Pneumonia, Mycoplasma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="Y">Procalcitonin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="Y">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009177" MajorTopicYN="N">Mycoplasma pneumoniae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007958" MajorTopicYN="N">Leukocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093743" MajorTopicYN="N">Random Forest</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword><Keyword MajorTopicYN="N">Acute respiratory infections</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clinical diagnostics</Keyword><Keyword MajorTopicYN="N">Computational method</Keyword><Keyword MajorTopicYN="N">Disease classification</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Random forest analysis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39349769</ArticleId><ArticleId IdType="pmc">PMC11442435</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-74057-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-74057-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of Disease Study 2013. Lancet 385, 117–171. 10.1016/s0140-6736(14)61682-2 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4340604</ArticleId><ArticleId IdType="pubmed">25530442</ArticleId></ArticleIdList></Reference><Reference><Citation>Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020). 10.1016/s0140-6736(20)30925-9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7567026</ArticleId><ArticleId IdType="pubmed">33069326</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z. J. et al. Etiological and epidemiological features of acute respiratory infections in China. Nat. Commun. 12, 5026. 10.1038/s41467-021-25120-6 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8373954</ArticleId><ArticleId IdType="pubmed">34408158</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S. Y., Shi, J., Zhuo, Y. &amp; Wang, T. Q. Impact of COVID-19 on the distribution of pathogenic bacteria in the lower respiratory tract of the elderly. Immun. Inflamm. Dis. 11, e931. 10.1002/iid3.931 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10336659</ArticleId><ArticleId IdType="pubmed">37506149</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, F. F. et al. Global morbidity and mortality of lower respiratory infections: a population -based study. Respir. Med. 205, 107042. 10.1016/j.rmed.2022.107042 (2022). https://doi.org:.</Citation><ArticleIdList><ArticleId IdType="pubmed">36462288</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow, E. J., Uyeki, T. M. &amp; Chu, H. Y. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat. Rev. Microbiol. 21, 195–210. 10.1038/s41579-022-00807-9 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X. et al. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg. Microbes Infect. 11, 1508–1517. 10.1080/22221751.2022.2078228 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9176688</ArticleId><ArticleId IdType="pubmed">35582916</ArticleId></ArticleIdList></Reference><Reference><Citation>Smedemark, S. A. et al. Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care. Cochrane Database Syst. Rev. 10, CD010130 (2022). 10.1002/14651858.CD010130.pub3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9575154</ArticleId><ArticleId IdType="pubmed">36250577</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, P., Wang, W., Zhang, X., Pan, J. &amp; Gong, L. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases. Sci. Rep. 14, 5632. 10.1038/s41598-024-55311-2 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10920782</ArticleId><ArticleId IdType="pubmed">38453960</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636–1643. 10.1038/s41591-020-1051-9 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y., Min, L. &amp; Zhang, X. Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections in children. BMC Pulm Med. 21, 386. 10.1186/s12890-021-01756-4 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8620633</ArticleId><ArticleId IdType="pubmed">34836530</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants, L. et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 369, m1328. 10.1136/bmj.m1328 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermeyer, Z. &amp; Emanuel, E. J. Predicting the future—big data, machine learning, and clinical medicine. N. Engl. J. Med. 375, 1216–1219. 10.1056/NEJMp1606181 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070532</ArticleId><ArticleId IdType="pubmed">27682033</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu, J., Wu, Q., Ding, G., Xu, Y. &amp; Feng, S. A survey of machine learning for big data processing. EURASIP J. Adv. Signal Process. 67 (2016). 10.1186/s13634-016-0355-x (2016).</Citation></Reference><Reference><Citation>Sarker, I. H. Data science and analytics: An overview from data-driven smart computing, decision-making and applications perspective. SN Comput. Sci. 2, 377. 10.1007/s42979-021-00765-8 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8274472</ArticleId><ArticleId IdType="pubmed">34278328</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman, L. Random forests. Mach. Learn. 45, 5–32 10.1023/A:1010933404324 (2001).</Citation></Reference><Reference><Citation>Shamsolmoali, P. et al. Image synthesis with adversarial networks: a comprehensive survey and case studies. Inform. Fusion 72, 126–146. 10.1016/j.inffus.2021.02.014 (2021). https://doi.org</Citation></Reference><Reference><Citation>Li, B. R., Zhuo, Y., Jiang, Y. Y. &amp; Zhang, S. Y. Random forest differentiation of Escherichia coli in elderly sepsis using biomarkers and infectious sites. Sci. Rep. 14, 12973. 10.1038/s41598-024-63944-6 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11153632</ArticleId><ArticleId IdType="pubmed">38839818</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoo, F., Singh, S. &amp; Meenakshi &amp; Comparison and analysis of logistic regression, Naïve Bayes and KNN machine learning algorithms for credit card fraud detection. Int. J. Inform. Technol. 13, 1503–1511 (2021).</Citation></Reference><Reference><Citation>Moore, J. B. &amp; June, C. H. Cytokine release syndrome in severe COVID-19. Science 368, 473–474. 10.1126/science.abb8925 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 130, 2620–2629. 10.1172/JCI137244 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, X. et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J. Allergy Clin. Immunol. 146, 110–118. 10.1016/j.jaci.2020.04.006 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7152876</ArticleId><ArticleId IdType="pubmed">32294485</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054–1062. 10.1016/S0140-6736(20)30566-3 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakagianni, A. et al. Prediction of COVID-19 mortality in the Intensive Care Unit using machine learning. Stud. Health Technol. Inf. 302, 536–540. 10.3233/shti230200 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37203743</ArticleId></ArticleIdList></Reference><Reference><Citation>Topol, E. J. High-performance medicine: the convergence of human and artificial intelligence. Nat. Med. 25, 44–56. 10.1038/s41591-018-0300-7 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30617339</ArticleId></ArticleIdList></Reference><Reference><Citation>Beam, A. L. &amp; Kohane, I. S. Big data and machine learning in health care. JAMA 319, 1317–1318. 10.1001/jama.2017.18391 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29532063</ArticleId></ArticleIdList></Reference><Reference><Citation>Escandón, K. et al. COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection. BMC Infect. Dis. 21, 710. 10.1186/s12879-021-06357-4 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8314268</ArticleId><ArticleId IdType="pubmed">34315427</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, B. et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin. Respir. J. 12, 1320–1360 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162259</ArticleId><ArticleId IdType="pubmed">28756639</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemayheu, G. et al. Children hospitalized with community-acquired pneumonia complicated by effusion: a single-centre retrospective cohort study. BMC Pediatr. 23, 181. 10.1186/s12887-023-04004-2 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113124</ArticleId><ArticleId IdType="pubmed">37072740</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). Chin. Med. J. (Engl) 133, 1087–1095. 10.1097/cm9.0000000000000819 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213636</ArticleId><ArticleId IdType="pubmed">32358325</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris, C. R. et al. Array programming with NumPy. Nature 585, 357–362. 10.1038/s41586-020-2649-2 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7759461</ArticleId><ArticleId IdType="pubmed">32939066</ArticleId></ArticleIdList></Reference><Reference><Citation>Reback, J. et al. pandas-dev/pandas: pandas 1.3.0. Zenodo. 10.5281/zenodo.3509134 (2020).</Citation></Reference><Reference><Citation>Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011). https://jmlr.org/papers/volume12/pedregosa11a/pedregosa11a.pdf</Citation></Reference><Reference><Citation>Hunter, J. D. Matplotlib: a 2D graphics environment. Comput. Sci. Eng. 9, 90–95. 10.1109/mcse.2007.55 (2007).</Citation></Reference><Reference><Citation>Lundberg, S. M. &amp; Lee, S. I. A unified approach to interpreting model predictions. Adv. Neural Inf. Process. Syst. 30, 4765–4774. https://proceedings.neurips.cc/paper/2017/file/8a20a8621978632d76c43dfd28b67767-Paper.pdf (2017).</Citation></Reference><Reference><Citation>Fawcett, T. An introduction to ROC analysis. Pattern Recognit. Lett. 27, 861–874. 10.1016/j.patrec.2005.10.010 (2006).</Citation></Reference><Reference><Citation>Saito, T. &amp; Rehmsmeier, M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS One 10, e0118432. 10.1371/journal.pone.0118432 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4349800</ArticleId><ArticleId IdType="pubmed">25738806</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>